Gilbert, AZ 的 乳癌 臨床試驗
9 項針對 乳癌 的研究正在 Gilbert（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
招募中1 期
- Research Site, Gilbert
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
招募中3 期
- Banner MD Anderson Cancer Center ( Site 0066), Gilbert
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
招募中3 期
- Banner MD Anderson Cancer Center-Oncology ( Site 0004), Gilbert
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
招募中3 期
- Ironwood Cancer & Research Centers, Gilbert
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
招募中3 期
- Banner Health MD Anderson AZ, Gilbert
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
招募中3 期
- Banner MD Anderson Cancer Center, Gilbert
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
招募中3 期
- Banner MD Anderson Cancer Center, Gilbert
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
招募中3 期
- Ironwood Cancer & Research Centers, Gilbert
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
招募中觀察性研究
- Banner - MD Anderson Cancer Center, Gilbert
其他城市的 乳癌 試驗
- New York City, NY134 項研究
- Houston, TX126 項研究
- Boston, MA111 項研究
- Nashville, TN80 項研究
- Los Angeles, CA72 項研究
- Edison, NJ68 項研究
- St. Louis, MO64 項研究
- Durham, NC63 項研究
- Queens, NY63 項研究
- Chicago, IL58 項研究
- Philadelphia, PA56 項研究
- Dallas, TX55 項研究
Gilbert 的其他研究
- 非小細胞肺癌12 項研究
- 大腸直腸癌9 項研究
- 肺癌8 項研究
- 癌症（所有類型）8 項研究
- 頭頸部鱗狀細胞癌6 項研究
- 轉移性癌症6 項研究
- 多發性骨髓瘤6 項研究
- 心臟衰竭6 項研究
- 心血管疾病6 項研究
- 膀胱癌6 項研究
- 非霍奇金淋巴瘤5 項研究
- 瀰漫性大B細胞淋巴瘤5 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。